These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 27495296)
1. Diagnosis and treatment based on quantitative PCR after controlled human malaria infection. Walk J; Schats R; Langenberg MC; Reuling IJ; Teelen K; Roestenberg M; Hermsen CC; Visser LG; Sauerwein RW Malar J; 2016 Aug; 15(1):398. PubMed ID: 27495296 [TBL] [Abstract][Full Text] [Related]
2. Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challenge. Talley AK; Healy SA; Finney OC; Murphy SC; Kublin J; Salas CJ; Lundebjerg S; Gilbert P; Van Voorhis WC; Whisler J; Wang R; Ockenhouse CF; Heppner DG; Kappe SH; Duffy PE PLoS One; 2014; 9(11):e109654. PubMed ID: 25405724 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial Guinea. Mpina M; Stabler TC; Schindler T; Raso J; Deal A; Acuche Pupu L; Nyakarungu E; Del Carmen Ovono Davis M; Urbano V; Mtoro A; Hamad A; Lopez MSA; Pasialo B; Eyang MAO; Rivas MR; Falla CC; García GA; Momo JC; Chuquiyauri R; Saverino E; Preston Church LW; Kim Lee Sim B; Manguire B; Tanner M; Maas C; Abdulla S; Billingsley PF; Hoffman SL; Jongo S; Richie TL; Daubenberger CA Malar J; 2022 Mar; 21(1):99. PubMed ID: 35331251 [TBL] [Abstract][Full Text] [Related]
5. Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection. Laurens MB; Billingsley P; Richman A; Eappen AG; Adams M; Li T; Chakravarty S; Gunasekera A; Jacob CG; Sim BK; Edelman R; Plowe CV; Hoffman SL; Lyke KE PLoS One; 2013; 8(7):e68969. PubMed ID: 23874828 [TBL] [Abstract][Full Text] [Related]
6. Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial. Bastiaens GJH; van Meer MPA; Scholzen A; Obiero JM; Vatanshenassan M; van Grinsven T; Sim BKL; Billingsley PF; James ER; Gunasekera A; Bijker EM; van Gemert GJ; van de Vegte-Bolmer M; Graumans W; Hermsen CC; de Mast Q; van der Ven AJAM; Hoffman SL; Sauerwein RW Am J Trop Med Hyg; 2016 Mar; 94(3):663-673. PubMed ID: 26711509 [TBL] [Abstract][Full Text] [Related]
7. The XN-30 hematology analyzer for rapid sensitive detection of malaria: a diagnostic accuracy study. Post A; Kaboré B; Reuling IJ; Bognini J; van der Heijden W; Diallo S; Lompo P; Kam B; Herssens N; Lanke K; Bousema T; Sauerwein RW; Tinto H; Jacobs J; de Mast Q; van der Ven AJ BMC Med; 2019 May; 17(1):103. PubMed ID: 31146732 [TBL] [Abstract][Full Text] [Related]
8. Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccines. Stanisic DI; Liu XQ; De SL; Batzloff MR; Forbes T; Davis CB; Sekuloski S; Chavchich M; Chung W; Trenholme K; McCarthy JS; Li T; Sim BK; Hoffman SL; Good MF Malar J; 2015 Apr; 14():143. PubMed ID: 25890156 [TBL] [Abstract][Full Text] [Related]
9. Measurement of parasitological data by quantitative real-time PCR from controlled human malaria infection trials at the Walter Reed Army Institute of Research. Kamau E; Alemayehu S; Feghali KC; Komisar J; Regules J; Cowden J; Ockenhouse CF Malar J; 2014 Jul; 13():288. PubMed ID: 25066459 [TBL] [Abstract][Full Text] [Related]
10. Reproducibility of malaria sporozoite challenge model in humans for evaluating efficacy of vaccines and drugs: a systematic review. Shibeshi W; Bagchus W; Yalkinoglu Ö; Tappert A; Engidawork E; Oeuvray C BMC Infect Dis; 2021 Dec; 21(1):1274. PubMed ID: 34930178 [TBL] [Abstract][Full Text] [Related]
11. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres. Mordmüller B; Supan C; Sim KL; Gómez-Pérez GP; Ospina Salazar CL; Held J; Bolte S; Esen M; Tschan S; Joanny F; Lamsfus Calle C; Löhr SJ; Lalremruata A; Gunasekera A; James ER; Billingsley PF; Richman A; Chakravarty S; Legarda A; Muñoz J; Antonijoan RM; Ballester MR; Hoffman SL; Alonso PL; Kremsner PG Malar J; 2015 Mar; 14():117. PubMed ID: 25889522 [TBL] [Abstract][Full Text] [Related]
12. Idiopathic acute myocarditis during treatment for controlled human malaria infection: a case report. van Meer MP; Bastiaens GJ; Boulaksil M; de Mast Q; Gunasekera A; Hoffman SL; Pop G; van der Ven AJ; Sauerwein RW Malar J; 2014 Jan; 13():38. PubMed ID: 24479524 [TBL] [Abstract][Full Text] [Related]
13. Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial. Walk J; Reuling IJ; Behet MC; Meerstein-Kessel L; Graumans W; van Gemert GJ; Siebelink-Stoter R; van de Vegte-Bolmer M; Janssen T; Teelen K; de Wilt JHW; de Mast Q; van der Ven AJ; Diez Benavente E; Campino S; Clark TG; Huynen MA; Hermsen CC; Bijker EM; Scholzen A; Sauerwein RW BMC Med; 2017 Sep; 15(1):168. PubMed ID: 28903777 [TBL] [Abstract][Full Text] [Related]
14. Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers. van Wolfswinkel ME; Langenberg MCC; Wammes LJ; Sauerwein RW; Koelewijn R; Hermsen CC; van Hellemond JJ; van Genderen PJ Malar J; 2017 Nov; 16(1):457. PubMed ID: 29126422 [TBL] [Abstract][Full Text] [Related]
15. Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites. Schats R; Bijker EM; van Gemert GJ; Graumans W; van de Vegte-Bolmer M; van Lieshout L; Haks MC; Hermsen CC; Scholzen A; Visser LG; Sauerwein RW PLoS One; 2015; 10(5):e0124243. PubMed ID: 25933168 [TBL] [Abstract][Full Text] [Related]
16. A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation. Murphy SC; Duke ER; Shipman KJ; Jensen RL; Fong Y; Ferguson S; Janes HE; Gillespie K; Seilie AM; Hanron AE; Rinn L; Fishbaugher M; VonGoedert T; Fritzen E; Kappe SH; Chang M; Sousa JC; Marcsisin SR; Chalon S; Duparc S; Kerr N; Möhrle JJ; Andenmatten N; Rueckle T; Kublin JG J Infect Dis; 2018 Feb; 217(5):693-702. PubMed ID: 29216395 [TBL] [Abstract][Full Text] [Related]
17. The Controlled Human Malaria Infection Experience at the University of Maryland. Friedman-Klabanoff DJ; Laurens MB; Berry AA; Travassos MA; Adams M; Strauss KA; Shrestha B; Levine MM; Edelman R; Lyke KE Am J Trop Med Hyg; 2019 Mar; 100(3):556-565. PubMed ID: 30675854 [TBL] [Abstract][Full Text] [Related]
18. A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study. McCarthy JS; Rückle T; Djeriou E; Cantalloube C; Ter-Minassian D; Baker M; O'Rourke P; Griffin P; Marquart L; Hooft van Huijsduijnen R; Möhrle JJ Malar J; 2016 Sep; 15(1):469. PubMed ID: 27624471 [TBL] [Abstract][Full Text] [Related]